Home > Regulatory Affairs, Training > EMA: Guideline on good pharmacovigilance practices (GVP): Product- or Population-Specific Considerations II: biological medicinal products
EMA: Guideline on good pharmacovigilance practices (GVP): Product- or Population-Specific Considerations II: biological medicinal products
Product- or Population-Specific Considerations II: biological medicinal products.
